Over the last decade we’ve seen powerful immunotherapies — checkpoint inhibitors, CAR-T cells, oncolytic viruses — reshape cancer treatment, but many patients still fail to respond. CPMV offers a new angle. This research illustrates a fundamental principle: the immune system can be re-educated not only…